24×7 Online Assistance Email researchnnnn@gmail.com WhatsApp support Hours 24×7
DM · Super-Speciality (Medical)

CKD & Special Nephrology Thesis Topics for DM Nephrology — 92+ titles

Updated November 2026 · reviewed against the current NMC / NBE curriculum

Hand-curated database of 92+ DM Nephrology (CKD & Special Nephrology) dissertation titles, each ready with objectives, synopsis structure and protocol guidance. Unlock the objectives of any title instantly, or get the complete thesis plan — no signup.

92+DM Nephrology (CKD & Special Nephrology) titles
24×7Instant objectives & thesis plans
100%Plagiarism-free, IEC-ready
Browse all 92 titles See a full thesis plan

DM Nephrology (CKD & Special Nephrology) — Thesis Title List

92 titles · instant objectives
  1. 001

    Correlation of diabetic retinopathy with severity of albuminuria in diabetic kidney disease

    CKD & CKD-MBD Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  2. 002

    Prevalence and etiology of anaemia in elderly patients with diabetic kidney disease

    CKD & CKD-MBD Prospective observational study Clinical Spectrum / Profile
    Objective
  3. 003

    Etiological profile and outcome of chronic kidney disease in elderly patients at a tertiary care hospital

    CKD & CKD-MBD Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  4. 004

    Demographic and clinical spectrum of chronic kidney disease with emphasis on mineral bone disorder

    CKD & CKD-MBD Retrospective record-based study Clinical Spectrum / Profile
    Objective
  5. 005

    Clinical and histological profile of chronic kidney disease of unknown etiology at a tertiary care hospital

    Special Nephrology Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  6. 006

    Serum vitamin D levels and their association with proteinuria in non-dialysis chronic kidney disease

    CKD & CKD-MBD Prospective observational study Association / Correlation
    Objective
  7. 007

    Prevalence of non-albuminuric diabetic kidney disease among patients with type 2 diabetes

    CKD & CKD-MBD Retrospective record-based study Diagnostic / Tool Evaluation
    Objective
  8. 008

    Prevalence of anaemia and iron deficiency in non-dialysis chronic kidney disease and its correlation with eGFR

    CKD & CKD-MBD Quasi-experimental study Comparative / Interventional
    Objective
  9. 009

    Burden of complications and mortality predictors in diabetic kidney disease at a tertiary care hospital

    CKD & CKD-MBD Prospective observational study Outcome / Prognostic
    Objective
  10. 010

    Relationship between serum uric acid and albuminuria in patients with diabetic kidney disease

    CKD & CKD-MBD Prospective observational study Association / Correlation
    Objective
  11. 011

    Cardiovascular risk factors and carotid intima-media thickness in non-dialysis chronic kidney disease

    CKD & CKD-MBD Retrospective record-based study Outcome / Prognostic
    Objective
  12. 012

    Comparative evaluation of multidisciplinary care approach and standard care in management of chronic kidney disease at a tertiary care hospital

    CKD & CKD-MBD Randomized controlled trial Comparative / Interventional
    Objective
  13. 013

    Prevalence and risk factors of diabetic kidney disease among patients with type 2 diabetes

    CKD & CKD-MBD Prospective observational study Outcome / Prognostic
    Objective
  14. 014

    Prescription pattern and adherence to KDIGO recommendations in management of non-dialysis chronic kidney disease

    CKD & CKD-MBD Retrospective record-based study Outcome / Prognostic
    Objective
  15. 015

    Serum phosphorus control and its association with vascular calcification in patients on maintenance haemodialysis

    CKD & CKD-MBD Retrospective record-based study Association / Correlation
    Objective
  16. 016

    Association of glycated haemoglobin with albuminuria and eGFR decline in diabetic kidney disease

    CKD & CKD-MBD Prospective observational study Association / Correlation
    Objective
  17. 017

    Prevalence and risk factors of peripheral arterial disease in patients with diabetic kidney disease

    CKD & CKD-MBD Prospective observational study Outcome / Prognostic
    Objective
  18. 018

    Serum intact parathyroid hormone levels and their association with mineral bone disorder in non-dialysis chronic kidney disease stages 3-5

    CKD & CKD-MBD Hospital-based cross-sectional study Association / Correlation
    Objective
  19. 019

    Rate of eGFR decline and its predictors in elderly patients with diabetic kidney disease

    CKD & CKD-MBD Hospital-based cross-sectional study Outcome / Prognostic
    Objective
  20. 020

    Prognostic value of KDIGO GFR-albuminuria risk categories for progression of diabetic kidney disease

    CKD & CKD-MBD Prospective analytical study Diagnostic / Tool Evaluation
    Objective
  21. 021

    Factors associated with prolonged hospital stay in chronic kidney disease at a tertiary care hospital

    CKD & CKD-MBD Hospital-based cross-sectional study Outcome / Prognostic
    Objective
  22. 022

    Role of renal Doppler in severity assessment and outcome prediction in chronic kidney disease at a tertiary care hospital

    CKD & CKD-MBD Prospective observational study Diagnostic / Tool Evaluation
    Objective
  23. 023

    Clinical profile, severity grading and outcome spectrum of diabetic kidney disease

    CKD & CKD-MBD Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  24. 024

    Assessment of fluid overload by bioimpedance analysis and its association with blood pressure and stage in non-dialysis chronic kidney disease

    CKD & CKD-MBD Prospective analytical study Diagnostic / Tool Evaluation
    Objective
  25. 025

    Clinical profile and comorbidity burden of diabetic kidney disease in elderly patients at a tertiary care hospital

    CKD & CKD-MBD Prospective analytical study Clinical Spectrum / Profile
    Objective
  26. 026

    Renal resistive index as a marker of disease severity and its correlation with albuminuria in diabetic kidney disease

    CKD & CKD-MBD Prospective analytical study Diagnostic / Tool Evaluation
    Objective
  27. 027

    Predictors of progression to end-stage kidney disease in elderly patients with chronic kidney disease stages 3-5

    CKD & CKD-MBD Retrospective record-based study Outcome / Prognostic
    Objective
  28. 028

    Clinical profile, severity grading and outcome spectrum of chronic kidney disease

    CKD & CKD-MBD Prospective observational study Clinical Spectrum / Profile
    Objective
  29. 029

    Prevalence of CKD-mineral bone disorder and its association with vascular calcification in diabetic kidney disease

    CKD & CKD-MBD Hospital-based cross-sectional study Association / Correlation
    Objective
  30. 030

    Prevalence of frailty and its association with hospitalisation in elderly patients with chronic kidney disease

    CKD & CKD-MBD Prospective observational study Clinical Spectrum / Profile
    Objective
  31. 031

    Prevalence of anaemia and its association with eGFR and albuminuria in diabetic kidney disease

    CKD & CKD-MBD Prospective analytical study Outcome / Prognostic
    Objective
  32. 032

    Effect of SGLT2 inhibitor therapy on albuminuria and eGFR in patients with diabetic kidney disease

    CKD & CKD-MBD Prospective interventional study Comparative / Interventional
    Objective
  33. 033

    Effectiveness of patient education intervention on quality of life among patients with diabetic kidney disease at a tertiary care hospital

    CKD & CKD-MBD Prospective interventional study Comparative / Interventional
    Objective
  34. 034

    Demographic and clinical spectrum of chronic kidney disease with emphasis on anemia control

    CKD & CKD-MBD Prospective analytical study Clinical Spectrum / Profile
    Objective
  35. 035

    Ultrasonographic kidney size and cortical echogenicity in relation to eGFR and severity of chronic kidney disease

    CKD & CKD-MBD Hospital-based cross-sectional study Diagnostic / Tool Evaluation
    Objective
  36. 036

    Correlation of urine albumin-creatinine ratio with severity and outcome in chronic kidney disease at a tertiary care hospital

    CKD & CKD-MBD Hospital-based cross-sectional study Association / Correlation
    Objective
  37. 037

    Prevalence of iron deficiency and its correlation with haemoglobin in non-dialysis chronic kidney disease

    CKD & CKD-MBD Retrospective record-based study Association / Correlation
    Objective
  38. 038

    Clinico-epidemiological profile of chronic kidney disease of unknown aetiology in agricultural communities

    CKD & CKD-MBD Community-based cross-sectional study Clinical Spectrum / Profile
    Objective
  39. 039

    Effect of SGLT2 inhibitors on eGFR decline and proteinuria in non-diabetic chronic kidney disease

    CKD & CKD-MBD Prospective observational study Outcome / Prognostic
    Objective
  40. 040

    Finerenone added to RAAS blockade in diabetic kidney disease: albuminuria reduction at six months

    CKD & CKD-MBD Prospective interventional study Comparative / Interventional
    Objective
  41. 041

    Serum FGF-23 and its association with left ventricular hypertrophy in CKD stages 3 to 5

    CKD & CKD-MBD Hospital-based cross-sectional study Association / Correlation
    Objective
  42. 042

    Prevalence of vascular calcification on lateral abdominal radiograph in non-dialysis chronic kidney disease

    CKD & CKD-MBD Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  43. 043

    Oral ferrous sulphate versus intravenous ferric carboxymaltose for anaemia in non-dialysis chronic kidney disease

    CKD & CKD-MBD Randomized controlled trial Comparative / Interventional
    Objective
  44. 044

    Roxadustat versus erythropoietin for anaemia of chronic kidney disease: haemoglobin response at 24 weeks

    CKD & CKD-MBD Prospective comparative study Comparative / Interventional
    Objective
  45. 045

    Protein-energy wasting and sarcopenia in CKD stages 3 to 5 and their association with mortality

    CKD & CKD-MBD Prospective observational study Association / Correlation
    Objective
  46. 046

    Prevalence of frailty in non-dialysis chronic kidney disease and its association with eGFR

    CKD & CKD-MBD Hospital-based cross-sectional study Association / Correlation
    Objective
  47. 047

    Cognitive impairment on the Montreal Cognitive Assessment in chronic kidney disease

    CKD & CKD-MBD Hospital-based cross-sectional study Association / Correlation
    Objective
  48. 048

    Depression on PHQ-9 in chronic kidney disease and dialysis patients and its association with quality of life

    CKD & CKD-MBD Hospital-based cross-sectional study Association / Correlation
    Objective
  49. 049

    Oral sodium bicarbonate and progression of chronic kidney disease with metabolic acidosis

    CKD & CKD-MBD Randomized controlled trial Comparative / Interventional
    Objective
  50. 050

    Prevalence and stage of chronic kidney disease among patients with type 2 diabetes attending a diabetes clinic

    CKD & CKD-MBD Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  51. 051

    Incidence of cisplatin-associated acute kidney injury and the role of urinary biomarkers

    Special Nephrology Prospective observational study Clinical Spectrum / Profile
    Objective
  52. 052

    Clinical profile and renal outcome of immune checkpoint inhibitor-associated kidney injury

    Special Nephrology Retrospective record-based study Clinical Spectrum / Profile
    Objective
  53. 053

    Incidence of tumour lysis syndrome in haematological malignancies receiving induction chemotherapy

    Special Nephrology Prospective observational study Clinical Spectrum / Profile
    Objective
  54. 054

    Renal recovery with bortezomib-based therapy in myeloma cast nephropathy

    Special Nephrology Retrospective record-based study Outcome / Prognostic
    Objective
  55. 055

    Persistence of proteinuria and hypertension three months after hypertensive disorders of pregnancy

    Special Nephrology Prospective observational study Outcome / Prognostic
    Objective
  56. 056

    Spectrum of kidney disease among people living with HIV on antiretroviral therapy

    Special Nephrology Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  57. 057

    Prevalence of albuminuria and kidney dysfunction in sickle cell disease

    Special Nephrology Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  58. 058

    Blood cadmium, arsenic and lead levels in chronic kidney disease of unknown aetiology compared with controls

    Special Nephrology Hospital-based cross-sectional study Association / Correlation
    Objective
  59. 059

    Metabolic evaluation by 24-hour urine analysis in recurrent kidney stone formers

    Special Nephrology Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  60. 060

    Renal outcome of type 1 cardiorenal syndrome in acute decompensated heart failure

    Special Nephrology Prospective observational study Outcome / Prognostic
    Objective
  61. 061

    Use of herbal and traditional medicines and its association with kidney injury

    Special Nephrology Hospital-based cross-sectional study Association / Correlation
    Objective
  62. 062

    Awareness of chronic kidney disease risk factors among patients with hypertension and diabetes

    Special Nephrology Hospital-based cross-sectional study Community / KAP
    Objective
  63. 063

    Magnitude of initial eGFR dip after SGLT2 inhibitor initiation and its association with 12-month kidney outcome in chronic kidney disease

    CKD & CKD-MBD Prospective observational study Outcome / Prognostic
    Objective
  64. 064

    Febuxostat versus no urate-lowering therapy in asymptomatic hyperuricaemia with CKD stages 3 and 4: eGFR decline at 12 months

    CKD & CKD-MBD Randomized controlled trial Comparative / Interventional
    Objective
  65. 065

    Sevelamer versus calcium acetate in non-dialysis CKD stages 4 and 5 with hyperphosphataemia: phosphate and FGF-23 control

    CKD & CKD-MBD Prospective comparative study Comparative / Interventional
    Objective
  66. 066

    Bone mineral density by DXA and its association with serum parathyroid hormone and alkaline phosphatase in CKD stages 3 to 5

    CKD & CKD-MBD Hospital-based cross-sectional study Association / Correlation
    Objective
  67. 067

    Ketoanalogue-supplemented very low-protein diet versus standard low-protein diet in CKD stage 4: eGFR decline and nutritional status

    CKD & CKD-MBD Randomized controlled trial Comparative / Interventional
    Objective
  68. 068

    Symptom burden and quality of life in elderly patients with CKD stage 5 on conservative kidney management

    CKD & CKD-MBD Prospective observational study Clinical Spectrum / Profile
    Objective
  69. 069

    Masked and white-coat hypertension on ambulatory blood pressure monitoring in non-dialysis chronic kidney disease

    CKD & CKD-MBD Hospital-based cross-sectional study Association / Correlation
    Objective
  70. 070

    sFlt-1/PlGF ratio in pre-eclampsia and its association with persistent kidney dysfunction at three months postpartum

    Special Nephrology Prospective observational study Association / Correlation
    Objective
  71. 071

    Change in kidney function and proteinuria after direct-acting antiviral therapy in hepatitis C-related kidney disease

    Special Nephrology Prospective observational study Outcome / Prognostic
    Objective
  72. 072

    Recurrence of kidney stones with potassium citrate therapy in hypocitraturic stone formers

    Special Nephrology Prospective observational study Outcome / Prognostic
    Objective
  73. 073

    Prevalence of renal artery stenosis on Doppler ultrasonography in young patients with resistant hypertension

    Special Nephrology Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  74. 074

    Total kidney volume by Mayo imaging classification and its association with eGFR decline in autosomal dominant polycystic kidney disease

    Special Nephrology Prospective observational study Association / Correlation
    Objective
  75. 075

    Semaglutide in diabetic kidney disease with obesity: change in urine albumin-creatinine ratio, eGFR and body weight at six months

    CKD & CKD-MBD Prospective interventional study Comparative / Interventional
    Objective
  76. 076

    Validation of the Kidney Failure Risk Equation for predicting kidney failure at two years in patients with CKD stages 3 to 5

    CKD & CKD-MBD Retrospective record-based study Diagnostic / Tool Evaluation
    Objective
  77. 077

    Achievement of the blood pressure target below 130/80 mmHg and its association with albuminuria in non-dialysis chronic kidney disease

    CKD & CKD-MBD Analytical cross-sectional study Association / Correlation
    Objective
  78. 078

    Desidustat for anaemia in non-dialysis chronic kidney disease: haemoglobin response, iron indices and safety at six months

    CKD & CKD-MBD Prospective observational study Outcome / Prognostic
    Objective
  79. 079

    Cinacalcet versus active vitamin D analogues for secondary hyperparathyroidism in maintenance haemodialysis: iPTH, calcium and phosphate control at six months

    CKD & CKD-MBD Prospective comparative study Comparative / Interventional
    Objective
  80. 080

    Frequency of hyperkalaemia-related discontinuation of renin-angiotensin system inhibitors in chronic kidney disease and its determinants

    CKD & CKD-MBD Analytical cross-sectional study Association / Correlation
    Objective
  81. 081

    Heat stress, hydration practices and kidney function among outdoor agricultural workers during the summer season

    Special Nephrology Community-based cross-sectional study Community / KAP
    Objective
  82. 082

    Clinical, serological and kidney biopsy profile of IgG4-related kidney disease and response to corticosteroids

    Special Nephrology Retrospective record-based study Clinical Spectrum / Profile
    Objective
  83. 083

    Incidence of proteinuria, hypertension and thrombotic microangiopathy with VEGF-pathway inhibitors in patients with solid tumours

    Special Nephrology Prospective observational study Outcome / Prognostic
    Objective
  84. 084

    Clinical profile, complement abnormalities and renal outcome of postpartum thrombotic microangiopathy

    Special Nephrology Hospital-based cross-sectional study Clinical Spectrum / Profile
    Objective
  85. 085

    Doppler ultrasonography rim sign versus contrast-enhanced CT for diagnosis of renal cortical necrosis in pregnancy-related acute kidney injury

    Special Nephrology Prospective analytical study Diagnostic / Tool Evaluation
    Objective
  86. 086

    Clinical, microbiological profile and outcome of carbapenem-resistant urinary tract infection in patients with chronic kidney disease

    Special Nephrology Prospective observational study Clinical Spectrum / Profile
    Objective
  87. 087

    Serum organophosphate and organochlorine pesticide residues in chronic kidney disease of unknown aetiology compared with CKD of known cause

    Special Nephrology Prospective analytical study Association / Correlation
    Objective
  88. 088

    Metformin versus standard care in autosomal dominant polycystic kidney disease with preserved eGFR: change in total kidney volume and eGFR at 12 months

    Special Nephrology Randomized controlled trial Comparative / Interventional
    Objective
  89. 089

    Maternal, fetal and kidney outcomes of pregnancy in women with pre-existing chronic kidney disease stages 1 to 3

    Special Nephrology Prospective observational study Outcome / Prognostic
    Objective
  90. 090

    Awareness of diagnosis, nephrotoxic drug avoidance and dietary measures among patients with chronic kidney disease stages 3 to 5

    CKD & CKD-MBD Hospital-based cross-sectional study Community / KAP
    Objective
  91. 091

    Performance of CKD-EPI 2021, EKFC and cystatin C-based equations against measured GFR by DTPA clearance in Indian adults with chronic kidney disease

    CKD & CKD-MBD Prospective analytical study Diagnostic / Tool Evaluation
    Objective
  92. 092

    Urinary KIM-1 and NGAL in normoalbuminuric type 2 diabetes and their association with eGFR decline at one year

    CKD & CKD-MBD Prospective analytical study Diagnostic / Tool Evaluation
    Objective

DM Nephrology (CKD & Special Nephrology) thesis — frequently asked questions

How many DM Nephrology (CKD & Special Nephrology) thesis topics are listed here?

92+ DM Nephrology (CKD & Special Nephrology) thesis topics are listed on this page, organised by subsection of the Nephrology (CKD & Special Nephrology) curriculum. Click "Get Objectives" on any title to unlock its aim, objectives and hypothesis instantly.

Do these Nephrology (CKD & Special Nephrology) topics include the objective and synopsis?

Yes. "Get Objectives" unlocks the research question, aim, primary and secondary objectives, hypothesis and outcome measures. "Full Plan" unlocks the complete synopsis: introduction, review of literature search terms, methodology, sample-size calculation, statistical plan, ethics and timeline — ready to download as Word or PDF.

Are these topics suitable for DNB, DM and FCPS Nephrology (CKD & Special Nephrology) candidates?

Yes — these Nephrology (CKD & Special Nephrology) dissertation titles are aligned with NMC, NBE and DNB Nephrology (CKD & Special Nephrology) curricula and are suitable for DM Nephrology (CKD & Special Nephrology), DNB Nephrology (CKD & Special Nephrology) and FCPS candidates alike. We can also tailor a title to your institution's preferred study design.

Can you help with synopsis writing, protocol, data analysis and journal publication?

Yes. Beyond topic selection we provide end-to-end support: synopsis writing (NMC / NBE format), IEC / IRB-ready protocol drafting, data collection forms, statistical analysis (SPSS / R / STATA), full thesis writing, plagiarism check (Turnitin), and journal publication assistance (SCOPUS, UGC-CARE, PubMed-indexed).

How fast can I get the objective for a topic?

Instantly. After payment, the objectives open on screen in under a minute and the full plan in 1–3 minutes, 24×7. You can also click "WhatsApp" on any title to talk to our team.

WhatsApp